Guidance Notes and Best Practice Guides
NICE: Leading experts have dismissed claims that the formula used by NICE to recommend which drugs are funded on the NHS is ‘flawed’ and say that it is still the best available method for assessing drugs.
A European Commission-funded study says that the method used by NICE called quality-adjusted life years (QALY) for assessing the value of new drug treatments does not reflect variations in views on illness & disability.
A European Commission-funded study says that the method used by NICE called quality-adjusted life years (QALY) for assessing the value of new drug treatments does not reflect variations in views on illness & disability.
QALYs looks at the cost of using a drug for a year and weighs it against how much someone's life can be extended & improved. Generally, if a treatment costs more than £20,000-30,000 per QALY, it would not be recommended as cost-effective by NICE. The findings of the study - which involved surveying 1,300 respondents in Belgium, France, Italy and the UK about the QALY - were presented at a conference in Brussels on health outcomes in Europe last week.
ScotGov: Vulnerable children will benefit from improved support from local services, following updated guidance from the Scottish Government. To further support practice the ScotGov has recently completed work on 3 manifesto commitments on child protection:
* The National Framework for child protection learning & development
* The Risk Assessment Framework
* Child Protection Guidance for Health professionals
TNA: Recently The National Archives have published an Agreement on Cooperation signed by the Information Commissioner and the Chief Executive & Keeper, The National Archives. This sets out how The National Archives and the Information Commissioner's Office (ICO) will co-operate as regulators of access to and re-use of public sector information.
.png)
